Heparin affects cytosolic glucose responses of hyperglycemic dividing mesangial cells

J Biol Chem. 2019 Apr 19;294(16):6591-6597. doi: 10.1074/jbc.RA119.007395. Epub 2019 Feb 5.

Abstract

Mesangial expansion underlies diabetic nephropathy, leading to sclerosis and renal failure. The glycosaminoglycan heparin inhibits mesangial cell growth, but the molecular mechanism is unclear. Here, rat mesangial cells (RMCs) were growth-arrested in the G0/G1 phase of cell division, stimulated to divide in normal glucose (5.6 mm) or high glucose (25.6 mm) with or without heparin, and analyzed for glucose uptake. We observed that RMCs entering the G1 phase in normal glucose with or without heparin rapidly cease glucose uptake. RMCs entering G1 in high glucose sustained glucose uptake for the first 3 h, and high-glucose exposure of RMCs only in the first 8 h of G1 induced the formation of an extracellular monocyte-adhesive hyaluronan matrix after cell division was completed. Moreover, a low heparin concentration under high-glucose conditions blocked glucose uptake by 1 h into G1 Of note, glucose transporter 4 (glut4) localized on the RMC surface at G0/G1 and was internalized into G1 cells under normal glucose conditions with or without heparin within 30 min. We also noted that, under high-glucose conditions, glut4 remained on the RMC surface for at least 2 h into G1 and was internalized by 4 h without heparin and within 1 h with heparin. These results provide evidence that the influx of glucose in hyperglycemic dividing RMCs initiates intermediate glucose metabolism, leading to increased cytosolic UDP sugars, and induces abnormal intracellular hyaluronan synthesis during the S phase of cell division.

Keywords: diabetic nephropathy; extracellular matrix; glomerular lesion; glucose transporter type 4 (GLUT4); glucose uptake; hyaluronan; hyperglycemia; inflammation; kidney disease; mesangial cells.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cells, Cultured
  • Dose-Response Relationship, Drug
  • Extracellular Matrix / metabolism
  • Glomerular Mesangium / metabolism*
  • Glomerular Mesangium / pathology
  • Glucose / metabolism*
  • Glucose Transporter Type 4 / metabolism*
  • Heparin / pharmacology*
  • Hyperglycemia / metabolism*
  • Hyperglycemia / pathology
  • Interphase / drug effects*
  • Rats

Substances

  • Glucose Transporter Type 4
  • Slc2a4 protein, rat
  • Heparin
  • Glucose